HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Helmi Pett Selected Research

artemisinin (artemisinine)

1/2017Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children.
6/2016Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Helmi Pett Research Topics

Disease

5Falciparum Malaria (Plasmodium falciparum Malaria)
01/2018 - 08/2014
4Malaria
01/2019 - 06/2016
2Hemolysis
01/2018 - 08/2014
2Glucosephosphate Dehydrogenase Deficiency
08/2015 - 08/2014
1Anemia
10/2019
1Vivax Malaria
10/2019
1Body Weight (Weight, Body)
01/2017
1Asymptomatic Infections
03/2016
1Myocardial Infarction
08/2011
1Hypercholesterolemia
08/2011

Drug/Important Bio-Agent (IBA)

6PrimaquineFDA Link
01/2018 - 08/2014
3EnzymesIBA
10/2019 - 08/2014
2Pharmaceutical PreparationsIBA
10/2019 - 01/2018
2artemisinin (artemisinine)IBA
01/2017 - 06/2016
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
10/2019
1pantothenamideIBA
01/2019
1piperaquineIBA
06/2016
1methyl 1- ribofuranosyl- 1,2,4- triazole- 3- carboxamidateIBA
06/2016
1artenimol (dihydroartemisinin)IBA
06/2016
1Lumefantrine Drug Combination Artemether (Coartem)FDA Link
03/2016
1Oxidoreductases (Dehydrogenase)IBA
08/2015
1Phosphates (Orthophosphate)IBA
08/2015
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
08/2014
1Antihypertensive Agents (Antihypertensives)IBA
08/2011
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2011
1CholesterolIBA
08/2011

Therapy/Procedure

2Therapeutics
01/2019 - 06/2016